Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May 2012 Volume 3 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May 2012 Volume 3 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts

  • Authors:
    • Shenglei Ge
    • Yitao Mao
    • Yan Yi
    • Dinghua Xie
    • Zhuchu Chen
    • Zhiqiang Xiao
  • View Affiliations / Copyright

    Affiliations: Department of Otolaryngology - Head and Neck Surgery, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, P.R. China, Department of Hematology, Second Xiang-ya Hospital, Central South University, Changsha, Hunan, P.R. China, Institute of Oncology, Xiang-ya Medical College, Central South University, Changsha, Hunan, P.R. China
  • Pages: 857-860
    |
    Published online on: February 13, 2012
       https://doi.org/10.3892/etm.2012.483
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Since the concept of the secretome (ensemble of proteins secreted and/or shed from cells) was proposed, it has become an attractive and challenging proteomic technology in recent years. However, secretome analysis still faces some difficulties mainly related to sample collection and preparation. In the present study, we established a reliable method for extracting secreted proteins by ultrafiltration centrifugation and conducting secretomic analysis. Accumulating evidence suggests that carcinoma-associated stromal fibroblasts (CAFs) play an important role in cancer initiation and progression. To investigate the expression patterns of secreted proteins from fibroblasts and to identify the secreted proteins involved in nasopharyngeal carcinoma (NPC) carcinogenesis, we conducted comparative secretome analysis between CAFs and normal fibroblasts. After two-dimensional gel electrophoresis (2-D PAGE), 11 significant spots were differentially expressed and identified by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). These proteins may take part in the regulation of the tumor microenvironment through different processes. The expression level of galectin-1 in the CAF supernatant was also determined by ELISA. This study provides useful information and new clues for the further understanding of the regulatory mechanisms of CAFs in the NPC microenvironment.

Introduction

As the most abundant cells in tumor stroma, tumor-associated fibroblasts or carcinoma-associated stromal fibroblasts (CAFs) have distinctly different morphological and biological characteristics compared with normal fibroblasts (NFs). CAFs may promote the malignant transformation of epithelial cells by secreting a variety of growth factors, cytokines, chemoattractants and enzymes. Scatter factor/hepatocyte growth factor, insulin growth factor, matrix metalloproteinases and fibroblast activation protein have been confirmed to play an important role in tumor-host crosstalk (1–3). Accumulating evidence suggests that CAFs play an important role in cancer initiation and progression (4). Co-culture system or three-dimensional (3D) culture system has been used to study the interaction between CAFs and cancer cells in recent years. However, the study of cells in 3D cultures has been hampered by the lack of simple methods to analyze them. Current techniques are time-consuming, require expensive equipment such as confocal microscopy for optimal results, and are poorly adapted for study (5,6). Moreover, these tumor-promoting properties of CAFs appear to be partially independent of the presence of tumor cells and are maintained in vitro even in the absence of epithelial cells (1,7). Therefore, it is feasible to isolate fibroblasts from carcinoma specimen and to culture in vitro for understanding the role of CAFs in the tumor microenvironment. Since the concept of the secretome (ensemble of proteins secreted and/or shed from cells) was proposed (8), it has become an attractive and challenging proteomic technology in recent years. However, secretome analysis still faces some difficulties mainly related to sample collection and preparation. In the present study, we explored one method of sample preparation, and we conducted secretome analysis of CAFs and NFs to evaluate the expression patterns of secreted proteins from fibroblasts in NPC carcinogenesis. The experimental results will provide a basis for the further understanding of the regulatory mechanisms of CAFs in the NPC microenvironment.

Materials and methods

Nasopharyngeal mucosal samples

All experimental procedures in this study were approved by the Ethics Committee of the Central South University School of Medicine. In total, 8 nasopharyngeal mucosal samples from patients with poorly differentiated nasopharyngeal squamous cell carcinoma and 8 from patients with sinusitis were obtained with informed consent at the Second Xiangya Hospital of Central South University. Diagnoses were pathologically confirmed, and none of the patients had received prior chemotherapy or radiation therapy.

Fibroblast culture

CAFs and NFs were obtained by tissue culture as described in detail elsewhere (9). Nasopharyngeal mucosa tissue was washed extensively with sterile PBS to remove contaminating debris and red blood cells, and cut into small pieces. Then cells were dissociated by 0.25% trypsin (Sigma, St. Louis, MO, USA) and purified using a curettage method combined with trypsinization. The outgrowing fibroblasts were cultivated with RPMI-1640 medium (Gibco, Life Technologies Inc, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Sigma) in an incubator set at 37°C and 5% CO2. Cells were transferred and plated into T-75 flasks. While cells were grown to 70% confluence, the culture medium was removed and cells were washed more than 3 times with Hank’s solution (Sigma), and then serum-free RPMI-1640 medium supplemented with 5 μg/ml transferrin and 5 μg/ml insulin were added to the culture for 72 h. For all experiments, cells used were passaged no more than three times.

Preparation of secreted protein samples

Culture medium was collected and centrifuged for 10 min at 1,000 × g, 10 min at 3,000 × g at 4°C to remove cell debris or dead cells. The supernatant was harvested and filtered through a membrane filter (nominal pore size 0.22 μm), and then secreted proteins were enriched and concentrated by ultrafiltration centrifugation (Millipore, Bedford, MA, USA). Finally, approximately 250 μl of the supernatant containing secreted proteins was obtained every time according to the CentriPlus Centrifugal Filter Device User Guide. Protein lysis buffer (2 mol/l thiourea, 7 mol/l urea, 40 mmol/l Tris, 4% CHAPS, 65 mol/l DTT) was added to the concentrated supernatant. The mixture was centrifuged for 30 min at 15,000 × g at 4°C and the final supernatant (ie. secreted proteins) was obtained. The protein concentration was measured using a 2D Quantitative kit (Amersham Biosciences, Piscataway, NJ, USA).

2-D PAGE

Aliquots containing approximately 600 μg of secreted protein extract were diluted in rehydration buffer for separation by isoelectrical focusing followed by SDS-PAGE (4–15% gradient gels) exactly in the same manner as previously described elsewhere (10). After SDS-PAGE, the gels were then stained with Coomassie blue staining solution overnight followed by destaining with 18% methanol and 5% acetic acid, Triplicate gels were made for each group.

Image analysis

2-D PAGE images were digitized with an Image scanner (Amersham Biosciences, Piscataway, NJ, USA) and image analysis was conducted using the PDQuest software (Bio-Rad, V7.1) as previously described in detail elsewhere (10).

Identification of proteins by MALDI-TOF MS

Protein spots showing temporal changes in expression in each group were excised and digested in-gel with sequencing-grade modified trypsin (Promega, Madison, WI, USA). Tryptic peptides were separated and analyzed using MALDI-TOF MS. The differentially expressed proteins were identified by peptide mass fingerprint (PMF), SWISS-PROT and NCBI protein databases searching using Mascot Distiller software exactly in the same manner as previously described (10).

Galectin-1 ELISA assay

CAF and NF culture media were collected, respectively, and applied to ELISA assay of galectin-1 in the supernatant.

Results

2-D PAGE

A reliable method for extracting secreted protein from conditioned medium was established. We isolated CAFs from cancer specimens and cultivated ex vivo for up to 3 passages. Secreted proteins were enriched from the culture supernatant by ultrafiltration centrifugation, and approximately 250 μl of the supernatant containing secreted proteins was finally obtained. The 2-D PAGE reference map of the secreted proteins from the fibroblasts was constructed. The differentially expressed proteins were selected and numbered by PDQuestTM (Fig. 1).

Figure 1.

Differentially expressed proteins were selected and numbered. 2-D PAGE of proteins secreted from (A) NFs and (B) CAFs.

Protein identification

Eleven significant spots were identified through MALDI-TOF MS and SWISS-PROT databases (Table I). These secreted protein were consistently expressed in both the CAF and NF supernatants, while 8 were differentially up-regulated in the CAF supernatant when compared with the NF supernatant. The other proteins were down-regulated including cystatin C, complement component C1s precursor and heterogeneous nuclear ribonucleoprotein A1. The concentration of galectin-1 in the supernatant was determined by ELISA. We detected a marked difference between the two groups indicating that CAFs may secrete more galectin-1 than NFs.

Table I.

Eleven spots obtained from 2-D PAGE identified via MALDI-TOF MS.

Table I.

Eleven spots obtained from 2-D PAGE identified via MALDI-TOF MS.

No.Accession no.Protein nameRelative molecular weight (kDa)Isoelectric point (pI)Variable multiplesa
1P04075Fructose bisphosphate aldolase A24.78.473.10
2P05121Plasminogen activator inhibitor 142.756.983.60
3P07711Cathepsin L37.95.322.50
4P08758Membrane annexin A535.35.152.90
5P3194714-3-3σ protein27.74.693.20
6P01034Cystatin C12.97.850.47
7P16035Complement component C1s precursor78.164.870.23
8P08294Cu/Zn-SOD16.25.855.20
9P09651Heterogeneous nuclear ribonucleoprotein A121.06.780.22
10P52565Rho-GDP dissociation inhibitor 12.26.743.90
11P09382Galectin 114.895.323.10

a Differential expression analysis of secreted protein spots between CAFs and NFs using the PDQuest software.

Discussion

As it is well known that secreted proteins play a key role in cell signaling, communication and migration, the investigation of secreted proteins has received increased attention in recent years. Secreted proteins are responsible for the crosstalk among cells and understanding this language can largely increase our knowledge concerning the molecular mechanisms of neoplasia. Significant technological advances in the field of proteomics during the last few years have provided shortcuts for the research of secreted proteins, and the concept of the secretome was correspondingly proposed. The secretome has facilitated the study of cell secreted proteins, and it may be a viable strategy for identifying candidate diagnostic and prognostic markers, potential drug and therapeutic targets (11,12). In the present experiment, we explored a set of methods with reference to other studies (13). At first, fibroblast cells were washed repeatedly more than 3 times to eliminate interference of bovine serum albumin, and then serum-free RPMI-1640 medium supplemented with transferrin and insulin as necessary nourishments was added to continue culture. Secondly, the culture medium was harvested and filtered through a 0.22-μm membrane filter. Thirdly, the culture medium was concentrated and desalinated by ultrafiltration centrifugation. The final step consisted of the lysis and denaturation of the concentrated secreted proteins using a solution composed of 2 mol/l thiourea, 7 mol/l urea, 4% CHAPS, 40 mmol/l Tris and 65 mol/l DTT.

Although we achieved success in the sample preparation approaches, many problems remain to be solved. The major defect of the method used in this experiment involved the complex operation used to enrich the secreted proteins and the large amount of cell medium required; 50 ml of culture medium was needed for approximately 250 μl of the supernatant containing the secreted proteins. In order to enrich the secreted proteins, the supernatant containing the secreted proteins was collected repeatedly and the mixture was repeatedly put through ultrafiltration centrifugation. Obviously, it is extremely important to develop simpler and more efficient approaches such as the nanozeolite-driven approach for enrichment of secretory proteins (14). This technique not only simplifies the operation order, but also saves time. Non-gel electrophoresis technology may also have important application value in secretome analysis such as nanoproteomics (15), capillary ultrafiltration and multidimensional liquid chromatographic separation in combination with mass spectrometry(16). However, 2-D PAGE which is rapidly being modified plays an irreplaceable role in proteomic analysis and is still the classical and most widely used proteomics method.

Secreted proteins from CAFs may influence the NPC pathological process in different ways. Among these secreted proteins, Cu/Zn-SOD and fructose bisphosphate aldolase A are associated with cellular oxidative reaction and play an important role in protecting cells against reactive oxygen species injury. Cathepsin L, cystatin C, plasminogen activator inhibitor-1, heterogeneous ribonucleoprotein A1, Rho-GDP dissociation inhibitor-1, 14-3-3σ protein and annexin A5 are associated with signal transduction involved in NPC invasion and metastasis (17–19). As a result, CAFs are involved in the regulation of the NPC microenvironment through these secreted proteins by different processes including protein degradation, cell proliferation, invasion and metastasis. Galectin 1 is one member of the family of β-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin 1 may participate in the regulation of the nasopharyngeal carcinoma microenvironment and its regulating mechanism remains unclear and is yet to be further clarified (20).

In conclusion, CAFs may influence the biological behavior of adjacent normal epithelial cells and cancer cells through secreted proteins in an autocrine or paracrine manner to maintain tumor microenvironment balance. Therefore, the fibroblast cell is not a silent character in carcinogenesis, and it plays an important role in this complex process, particularly in the regulation of the tumor microenvironment. Although the 3D culture system is too complex for operation, its application and investigation warrant future efforts since it may have broad application prospects in the field of secretome analysis of CAFs.

Acknowledgements

This study was financially supported by the National Natural Science Foundation of China (grant nos. 30700940 and 81100360).

References

1. 

Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005. View Article : Google Scholar

2. 

Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD and Rowley DR: Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 65:8887–8895. 2005. View Article : Google Scholar : PubMed/NCBI

3. 

Maeda T, Desouky J and Friedl A: Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis. Oncogene. 25:1408–1412. 2006. View Article : Google Scholar : PubMed/NCBI

4. 

Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature. 432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI

5. 

Yamada KM and Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell. 130:601–610. 2007. View Article : Google Scholar : PubMed/NCBI

6. 

Debnath J and Brugge JS: Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer. 5:675–688. 2005. View Article : Google Scholar : PubMed/NCBI

7. 

Hu M, Yao J, Cai L, Bachman KE, van den Brûle F, Velculescu V and Polyak K: Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 37:899–905. 2005. View Article : Google Scholar : PubMed/NCBI

8. 

Tjalsma H, Bolhuis A, Jongbloed JD, Bron S and van Dijl JM: Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev. 64:515–547. 2000. View Article : Google Scholar : PubMed/NCBI

9. 

Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, Simon W, Mürdter TE and Aulitzky WE: Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC Cancer. 8:3642008. View Article : Google Scholar : PubMed/NCBI

10. 

Feng XP, Yi H, Li MY, Li XH, Yi B, Zhang PF, Li C, Peng F, Tang CE, Li JL, Chen ZC and Xiao ZQ: Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res. 70:3450–3562. 2010. View Article : Google Scholar : PubMed/NCBI

11. 

May M: From cells, secrets of the secretome leak out. Nat Med. 15:8282009. View Article : Google Scholar : PubMed/NCBI

12. 

Pavlou MP and Diamandis EP: The cancer cell secretome: a good source for discovering biomarkers? J Proteomics. 73:1896–1906. 2010.PubMed/NCBI

13. 

Boraldi F, Bini L, Liberatori S, Armini A, Pallini V, Tiozzo R, Ronchetti IP and Quaglino D: Normal human dermal fibroblasts: proteomic analysis of cell layer and culture medium. Electrophoresis. 24:1292–1310. 2003. View Article : Google Scholar : PubMed/NCBI

14. 

Cao J, Hu Y, Shen C, Yao J, Wei L, Yang F, Nie A, Wang H, Shen H, Liu Y, Zhang Y, Tang Y and Yang P: Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells. Proteomics. 9:4881–4888. 2009. View Article : Google Scholar : PubMed/NCBI

15. 

Archakov AI, Ivanov YD, Lisitsa AV and Zgoda VG: AFM fishing nanotechnology is the way to reverse the Avogadro number in proteomics. Proteomics. 7:4–9. 2007. View Article : Google Scholar : PubMed/NCBI

16. 

Huang CM, Wang CC, Barnes S and Elmets CA: In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics. 6:5805–5814. 2006. View Article : Google Scholar : PubMed/NCBI

17. 

Xu X, Yuan G, Liu W, Zhang Y and Chen W: Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance. Exp Oncol. 31:102–105. 2009.PubMed/NCBI

18. 

Tang CE, Guan YJ, Yi B, Li XH, Liang K, Zou HY, Yi H, Li MY, Zhang PF, Li C, Peng F, Chen ZC, Yao KT and Xiao ZQ: Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J Proteome Res. 9:6101–6111. 2010.

19. 

Yi B, Tan SX, Tang CE, Huang WG, Cheng AL, Li C, Zhang PF, Li MY, Li JL, Yi H, Peng F, Chen ZC and Xiao ZQ: Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem. 106:858–866. 2009. View Article : Google Scholar : PubMed/NCBI

20. 

Tang CE, Tan T, Li C, Chen ZC, Ruan L, Wang HH, Su T, Zhang PF and Xiao ZQ: Identification of galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis. Oncol Rep. 24:495–500. 2010.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ge S, Mao Y, Yi Y, Xie D, Chen Z and Xiao Z: Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts. Exp Ther Med 3: 857-860, 2012.
APA
Ge, S., Mao, Y., Yi, Y., Xie, D., Chen, Z., & Xiao, Z. (2012). Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts. Experimental and Therapeutic Medicine, 3, 857-860. https://doi.org/10.3892/etm.2012.483
MLA
Ge, S., Mao, Y., Yi, Y., Xie, D., Chen, Z., Xiao, Z."Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts". Experimental and Therapeutic Medicine 3.5 (2012): 857-860.
Chicago
Ge, S., Mao, Y., Yi, Y., Xie, D., Chen, Z., Xiao, Z."Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts". Experimental and Therapeutic Medicine 3, no. 5 (2012): 857-860. https://doi.org/10.3892/etm.2012.483
Copy and paste a formatted citation
x
Spandidos Publications style
Ge S, Mao Y, Yi Y, Xie D, Chen Z and Xiao Z: Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts. Exp Ther Med 3: 857-860, 2012.
APA
Ge, S., Mao, Y., Yi, Y., Xie, D., Chen, Z., & Xiao, Z. (2012). Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts. Experimental and Therapeutic Medicine, 3, 857-860. https://doi.org/10.3892/etm.2012.483
MLA
Ge, S., Mao, Y., Yi, Y., Xie, D., Chen, Z., Xiao, Z."Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts". Experimental and Therapeutic Medicine 3.5 (2012): 857-860.
Chicago
Ge, S., Mao, Y., Yi, Y., Xie, D., Chen, Z., Xiao, Z."Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts". Experimental and Therapeutic Medicine 3, no. 5 (2012): 857-860. https://doi.org/10.3892/etm.2012.483
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team